High-MSI CRCs may develop from a subset of hyperplastic polyps (which often have BRAF mutations and CIMP-H), and microsatellite-stable cancers with BRAF mutations may develop from adenomas with BRAF mutations. This evidence concerns the gene BRAF and hyperplastic polyp.